DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis

Clinica Chimica Acta

Volumn 381, Issue 1, 2007, Pages 50-55

  Basso, Daniela ^a   Navaglia, Filippo ^a   Fogar, Paola ^b   Zambon, Carlo Federico ^b   Greco, Eliana ^a   Schiavon, Stefania ^a   Fasolo, Michela ^a   Stranges, Alessia ^a   Falda, Alessandra ^a   Padoan, Andrea ^a   Fadi, Elisa ^a   Pedrazzoli, Sergio ^b,c   Plebani, Mario ^a,c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

DNA repair pathways; Gastrointestinal carcinogenesis; Gene polymorphisms; Mitochondrial DNA; Pancreatic cancer

Indexed keywords

MITOCHONDRIAL DNA;

CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DNA POLYMORPHISM; DNA REPAIR; ESOPHAGUS CANCER; EXCISION REPAIR; GASTROINTESTINAL TRACT; GENE MUTATION; GENETIC PREDISPOSITION; HOMOLOGOUS RECOMBINATION; HUMAN; MISMATCH REPAIR; ONSET AGE; PANCREAS CANCER; PRIORITY JOURNAL; REVIEW; SMOKING; SOMATIC MUTATION; STOMACH CANCER; X RAY;

ANIMALS; DNA MISMATCH REPAIR; DNA REPAIR; DNA, MITOCHONDRIAL; GASTROINTESTINAL NEOPLASMS; HUMANS; MUTATION; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 34248174044     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.02.020     Document Type: Review

References (60)

1. Lindahl T. Instability and decay of the primary structure of DNA. Nature 362 (1993) 709-715
2. Slupphaug G., Kavly B., and Krokan H.E. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 531 (2003) 231-251
3. Hecht S.S. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424 (1999) 127-142
4. Drabløs F., Feyzi E., Arne Aas P., et al. Alkylation damage in DNA and RNA - repair mechanisms and medical significance. DNA Repair 3 (2004) 1389-1407
5. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
6. Nilsen H., and Krokan H.E. Base excision repair in a network of defence and tolerance. Carcinogenesis 22 (2001) 987-998
7. Lainé J.-P., and Egly J.-M. When transcription and repair meet: a complex system. Trends Genet 22 (2006) 430-436
8. Wood R.D., Mitchel M., Sgouros J., and Lindahl T. Human DNA repair genes. Science 291 (2001) 1284-1289
9. Christmann M., Tomicic M.T., Roos W.P., and Kaina B. Mechanisms of human DNA repair: an update. Toxicology 193 (2003) 3-34
10. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat Rev 1 (2001) 22-33
11. Risinger M.A., and Groden J. Crosslinks and crosstalk: human cancer syndromes and DNA repair defects. Cancer Cell 6 (2004) 539-545
12. Kennedy R.D., and D'Andrea A. DNA repair pathways in clinical practice: lessons from pediatric cancer susceptibility syndromes. J Clin Oncol 24 (2006) 3799-3808
13. Grady W.M. Genetic testing for high-risk colon cancer patients. Gastroenterology 124 (2003) 1574-1594
14. Söreide K., Janssen E.A.M., Söiland H., Körner H., and Baak J.P.A. Microsatellite instability in colorectal cancer. Br J Surg 93 (2006) 395-406
15. Peltomaki P. Lynch syndromes genes. Fam Cancer 4 (2005) 227-232
16. Lawes D.A., SenGupta S., and Boulos P.B. The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 29 (2003) 201-212
17. Ilyas M., Straub J., Tomlinson I.P.M., and Bodmer W.F. Genetic pathways in colorectal and other cancers. Eur J Cancer 35 (1999) 1986-2002
18. Calvert P.M., and Frucht H. The genetics of colorectal cancer. Ann Intern Med 137 (2002) 603-612
19. Jacob S., and Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 84 (2002) 27-47
20. Oda S., Zhao Y., and Maehara Y. Microsatellite instability in gastrointestinal tract cancers: a brief update. Surg Today 35 (2005) 1005-1015
21. Máximo V., Soares P., Seruca R., Rocha A.S., Castro P., and Sobrinho-Simões M. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer 32 (2001) 136-143
22. Garay J., Bravo J.C., Correa P., and Schneider B.G. Infrequency of microsatellite instability in complete and incomplete gastric intestinal metaplasia. Human Pathol 35 (2004) 102-106
23. Rugge M., Bersani G., Bertorelle R., et al. Microsatellite instability and gastric non-invasive neoplasia in a high risk population in Cesena, Italy. J Clin Pathol 58 (2005) 805-810
24. Beghelli S., de Manzoni G., Barbi S., et al. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery 139 (2006) 347-356
25. Mirchandani K.D., and D'Andrea A.D. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res 312 (2006) 2647-2653
26. Hahn S.A., Greenhalf B., Ellis I., et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95 (2003) 214-221
27. Thacker J., and Zdzienicka M.Z. The mammalian XRCC genes: their roles in DNA repair and genetic stability. DNA Repair 2 (2003) 655-672
28. Hung R.J., Hall J., Brennan P., and Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162 (2005) 925-942
29. Lowenfels A.B., and Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem 95 (2005) 649-656
30. Fernández-Silva P., Enriquez J.A., and Montoya J. Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 88.1 (2003) 41-56
31. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125 (2006) 1241-1252
32. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat Med 6 (2000) 513-519
33. Saelens X., Festjens N., Vande Walle L., van Gurp M., Van Loo G., and Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 23 (2004) 2861-2874
34. Green D.R. Apoptotic pathways: ten minutes to dead. Cell 121 (2005) 671-674
35. Van Houten B., Woshner V., and Santos J.H. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair 5 (2006) 145-152
36. Selak M.A., Armour S.M., MacKenzie E.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7 (2005) 77-85
37. Richard S.M., Bailliet G., Páez G.L., Bianchi M.S., Peltomäki P., and Bianchi N.O. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 60 (2000) 4231-4237
38. Coller H.A., Khrapko K., Bodyak N.D., Nekhaeva E., Herrero-Jimenez P., and Thilly W.G. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28 (2001) 147-150
39. Hibi K., Nakayama H., Yamazaki T., et al. Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 92 (2001) 319-321
40. Carew J.S., and Huang P. Mitochondrial defects in cancer. Mol Cancer I (2002) 9
41. Nomato S., Yamashita K., Koshikawa K., Nakao A., and Sidransky D. Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 8 (2002) 481-487
42. Chen J.Z., Gokden N., Greene G.F., Green B., and Kadlubar F.F. Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis 24 (2003) 1481-1487
43. Eng C., Kiuru M., Fernandez M., and Aaltonen L.A. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3 (2003) 193-202
44. Enns G.M. The contribution of mitochondria to common disorders. Mol Genet Metab 80 (2003) 11-26
45. Wong L.-J.C., Lueth M., Li X.-N., Lau C.C., and Vogel H. Detection of mitochondrial DANN mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res 63 (2003) 3866-3871
46. Liu V.W.S., Yang H.J., Wang Y., et al. High frequency of mitochondrial genome instability in human endometrial carcinomas. Br J Cancer 89 (2003) 697-701
47. Matsuyama W., Nakagawa M., Wakimoto J., Hirotsu Y., Kawabata M., and Osame M. Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum Mutat 21 (2003) 441-443
48. Jakupciak J.P., Wang W., Markowitz M.E., et al. Mitochondrial DNA as a cancer biomarker. J Mol Diagn 7 (2005) 258-267
49. Maassen J.A., Janssen G.M.C., and Hart L.M. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37 (2005) 213-221
50. Nishikawa M., Oshitani N., Matsumoto T., Nishigami T., Arakawa T., and Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br J Cancer 93 (2005) 331-337
51. Petros J.A., Baumann A.K., Ruiz-Pesini E., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102 (2005) 719-724
52. Kang D., and Hamasaki N. Alterations of mitochondrial DNA in common diseases and disease states: aging, neurodegeneration, heart failure, diabetes and cancer. Curr Med Chem 12 (2005) 429-441
53. Chatterjee A., Mambo E., and Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 25 (2006) 4663-4674
54. Ohta S. Contribution of somatic mutations in the mitochondrial menome to the development of cancer and tolerance against anticancer drugs. Oncogene 25 (2006) 4768-4776
55. Yoneyama H., Hara T., Kato Y., Yamori T., Matsuura E.T., and Koike K. Nucleotide sequence variation is frequent in the mitochondrial DNA displacement loop region of individual tumor cells. Mol Cancer Res 3 (2005) 14-20
56. Navaglia F., Basso D., Fogar P., et al. Mitochondrial DNA D-loop in pancreatic cancer. Somatic mutations are epiphenomena while the germline 16519T variant worsens metabolism and outcome. Am J Clin Pathol 126 (2006) 593-601
57. Basso D., Greco E., Fogar P., et al. Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause?. Clin Chim Acta 372 (2006) 120-128
58. Berdanier C.D. Diabetes and nutrition: the mitochondrial part. J Nutr 131 (2001) 344S-353S
59. Miyazono F., Schneider P.M., Metzger R., et al. Mutations in the mitochondrial DANN D-loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene 21 (2002) 3780-3783
60. Hiyama T., Tanaka S., Shima H., et al. Somatic mutation of mitochondrial DNA in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Mol Med 12 (2003) 169-174